Sweden's NeuroNova has identified a convenient and accessible source of neural stem cells in the ependymal layer of the brain. The company hopes to use such cells for transplantation therapy in Parkinson's disease and as a platform for drug discovery.
S-11433 Stockholm, Sweden
Phone: (46) 8786 0901
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
With financial help from the founder of Uniqlo, Japan’s leading facility for induced pluripotent stem cells is aiming to automate production to slash costs and kick-start R&D in the field.
A partnership with Germfree Laboratories will bring a new facility to boost Saudi Arabia’s biotech sector as the world’s largest oil exporter tries to establish itself as a global biotech hub by 2040.
The off-the-shelf stem cell therapy shows sustained glycemic control and a high rate of insulin independence.
The drugmaker presented data at a lymphoma meeting showing strong efficacy for the CAR-T in marginal zone lymphoma, the second most common indolent lymphoma.
While some are calling for Syncona to be wound up, the UK-based company believes many existing and new investors will back the creation of new private fund.
Oral RNA splicing modulator has gone into a Phase II/III trial
The country’s life sciences investment head tells Scrip that it is business as usual for the sector despite the rumblings from across the Atlantic.
